We at Fitch Solutions expect the Cuban pharmaceutical market will continue its growth trajectory. The country’s ageingpopulation, as well as the government’s free provision of healthcare and medicines, will continue to operate as the main factorsdriving medicine sales. However, increasing US sanctions on Cuba, a poor intellectual property environment and a relativelycompetitive domestic industry make Cuba a highly challenging market with few opportunities for multinational drugmakers. Cubawill remain among the least attractive markets in the Americas.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook